Paliperidone and Benztropine mesylate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paliperidone and Benztropine mesylate. Common interactions include dehydration among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people who take Paliperidone and Benztropine mesylate have. It is created by eHealthMe based on reports of 38 people who take Paliperidone and Benztropine mesylate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 26, 2022

38 people who take Paliperidone and Benztropine mesylate together, and have interactions are studied.


What is Paliperidone?

Paliperidone has active ingredients of paliperidone. eHealthMe is studying from 4,009 Paliperidone users for its effectiveness, alternative drugs and more.

What is Benztropine mesylate?

Benztropine mesylate has active ingredients of benztropine mesylate. It is often used in movement - uncontrolled or slow. eHealthMe is studying from 3,600 Benztropine mesylate users for its effectiveness, alternative drugs and more.

Number of Paliperidone and Benztropine mesylate reports submitted per year:

Paliperidone and Benztropine mesylate drug interactions.

Common Paliperidone and Benztropine Mesylate drug interactions by gender *:

female:

  1. Dehydration
  2. Drug ineffective
  3. Fatigue
  4. Fluid intake reduced
  5. Heart rate increased
  6. Hunger
  7. Hyperprolactinaemia
  8. Hypertension
  9. Hypotension
  10. Middle insomnia

male:

  1. Neutropenia
  2. Abnormal behaviour
  3. Musculoskeletal stiffness
  4. Poor quality sleep
  5. Neuroleptic malignant syndrome
  6. Respiratory failure
  7. Akathisia
  8. Anorgasmia
  9. Blood creatine phosphokinase increased
  10. Chest pain

Common Paliperidone and Benztropine Mesylate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthenia
  2. Breast tenderness
  3. Decreased appetite
  4. Delusion of grandeur
  5. Depression
  6. Disturbance in attention
  7. Electrocardiogram qt prolonged
  8. Electrocardiogram st segment elevation
  9. Hallucinations, mixed
  10. Homicidal ideation

30-39:

  1. Neuroleptic malignant syndrome
  2. Respiratory failure
  3. Congestive cardiomyopathy
  4. Hypertension
  5. Myocardial infarction
  6. Abnormal behaviour
  7. Agitation
  8. Catatonia
  9. Chronic hepatitis
  10. Chronic kidney disease

40-49:

  1. Abnormal behaviour
  2. Hallucination, auditory
  3. Impaired self-care
  4. Neutropenia
  5. Acarodermatitis
  6. Delusion
  7. Dermatitis atopic
  8. Herpes simplex
  9. Psychotic disorder
  10. Agranulocytosis

50-59:

  1. Drug ineffective
  2. Dyspnoea
  3. Ejection fraction decreased
  4. Electrocardiogram st segment elevation
  5. Granulocytopenia
  6. Hypotension
  7. Leukopenia
  8. Middle insomnia
  9. Monocytosis
  10. Myocarditis

60+:

  1. Asthenia
  2. Constipation
  3. Delirium
  4. Neurotoxicity
  5. Tremor

Common conditions people have *:

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 11 people, 28.95%
  2. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 7 people, 18.42%
  3. Stress And Anxiety: 4 people, 10.53%
  4. Pain: 4 people, 10.53%
  5. Insomnia (sleeplessness): 4 people, 10.53%
  6. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 4 people, 10.53%
  7. Depression: 4 people, 10.53%
  8. Constipation: 4 people, 10.53%
  9. Sleep Disorder: 3 people, 7.89%
  10. Asthma: 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Paliperidone and Benztropine mesylate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Paliperidone and Benztropine mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Paliperidone side effects:

Browse all side effects of Paliperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benztropine mesylate side effects:

Browse all side effects of Benztropine mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Paliperidone interactions:

Browse all interactions between Paliperidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benztropine mesylate interactions:

Browse all interactions between Benztropine mesylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone and benztropine mesylate (the active ingredients of Paliperidone and Benztropine mesylate, respectively), and Paliperidone and Benztropine mesylate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Paliperidone and Benztropine mesylate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: